Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization | springermedicine.com

Springer Medicine

Top

Frontiers of Medicine

Published in:

01-03-2016 | Commentary

Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization

Authors: Shuyang Sun, Zhiyuan Zhang

Published in: Frontiers of Medicine | Issue 1/2016

Login to get access

Title: Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization
Authors: Shuyang Sun
Zhiyuan Zhang
Publication date: 01-03-2016
Publisher: Higher Education Press
Published in: Frontiers of Medicine / Issue 1/2016
Print ISSN: 2095-0217
Electronic ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-016-0432-4

Home
Congress Coverage
Clinical Collections
- Advances in Alzheimer’s
About Springer Medicine
Key Specialties